Verto
Paris-based independent growth and buyout PE firm founded 2016 by Antoine Dary, specializing in B2B Software and HealthTech investments across France, Benelux and Switzerland with EUR 15-60M tickets. Manages around EUR 470M across Verto Growth I (2020 EUR 140M Harvesting) and Verto Growth II (2025 EUR 330M final close July 2025 hard cap, Investing); notable exits BioBank August 2024 to IK Partners and Presto Engineering 2024 to Dentressangle Capital.
Key facts
Recent exits
Coverage notes
2 funds tracked, 14 portfolio companies (11 active · 3 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
14 companiesFunds & portfolio
Every fund Verto has raised, with its portfolio companies. Hand-checked from public filings.
Verto Growth IIGrowth2025 · 1yr€330M3 active
Unrealized
3 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| TMT |  France | 2025 | |
| TMT | France | 2022 | |
| TMT | France | 2025 |
France· Entry 2025France· Entry 2022France· Entry 2025Verto Growth IGrowthHarvesting2020 · 6yr€140M8 active · 3 realized
Unrealized
8 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| HealthTech | France | 2019 | |
| TMT | France | 2020 | |
| Business Services | France | 2021 | |
| TMT | France | 2021 | |
| Healthcare | France | 2022 | |
| TMT | France | 2020 | |
| Industrials | France | 2018 | |
| TMT | France | 2021 |
France· Entry 2019France· Entry 2020France· Entry 2021France· Entry 2021France· Entry 2022France· Entry 2020France· Entry 2018France· Entry 2021Realized
3 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Healthcare | France | 2015 | 2024 | Secondary | – | ||
| TMT | France | 2019 | 2023 | Secondary | – | ||
| Industrials | France | 2018 | 2024 | Secondary | – |
Saved GPs appear in your watchlist, one click from your workspace.
About Verto
Verto is a Paris-based independent growth and buyout private equity firm with €470 million of assets under management, founded in 2016 by Antoine Dary. The firm specialises in B2B Software and HealthTech investments across France, Benelux and Switzerland, deploying capital across Verto Growth I and II vintage funds with equity tickets ranging from €15 million to €60 million per transaction.
Investment thesis
Verto targets European B2B Software and HealthTech companies at growth equity and selective buyout stages, with sector focus on enterprise software, vertical SaaS, healthcare technology and selective fintech verticals. The pan-European mandate covering France, Benelux and Switzerland provides distinctive deal flow across French-speaking and DACH-adjacent European tech markets. Equity ticket sizes enable Verto to participate in scaling rounds for profitable European tech companies.
Recent activity
Recent realised exits include BioBank (healthcare, 2024) and Presto Engineering (industrials, 2024), reflecting active distribution across the B2B technology portfolio. The platform tracks 2 funds and 11 active portfolio companies across the multi-vintage European tech programme. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
France·€470M
France·€480MFrance·€480M
France·€458M
France·€450M
France·€500M
France·€500M
France·€500M
France·€435M
France·€510M
France·€424M
France·€423MGet the full picture on Verto.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in